Page last updated: 2024-11-01

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Hypotension

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Hypotension in 3 studies

N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.

Hypotension: Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tunctan, B1
Korkmaz, B1
Cuez, T1
Kemal Buharalioglu, C1
Sahan-Firat, S1
Falck, J1
Malik, KU1
Domoki, F1
Nagy, K1
Temesvári, P1
Bari, F1
Leach, M1
Hamilton, LC1
Olbrich, A1
Wray, GM1
Thiemermann, C1

Other Studies

3 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Hypotension

ArticleYear
Contribution of vasoactive eicosanoids and nitric oxide production to the effect of selective cyclooxygenase-2 inhibitor, NS-398, on endotoxin-induced hypotension in rats.
    Basic & clinical pharmacology & toxicology, 2010, Volume: 107, Issue:5

    Topics: Animals; Blood Pressure; Cyclooxygenase 2 Inhibitors; Eicosanoids; Hypotension; Lipopolysaccharides;

2010
Selective inhibitors differentially affect cyclooxygenase-dependent pial arteriolar responses in newborn pigs.
    Pediatric research, 2005, Volume: 57, Issue:6

    Topics: Acetaminophen; Animals; Animals, Newborn; Arterioles; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxyge

2005
Effects of inhibitors of the activity of cyclo-oxygenase-2 on the hypotension and multiple organ dysfunction caused by endotoxin: a comparison with dexamethasone.
    British journal of pharmacology, 1998, Volume: 124, Issue:3

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyc

1998